{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T11:48:04Z","timestamp":1791287284385,"version":"4.1.0"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,8,22]],"date-time":"2013-08-22T00:00:00Z","timestamp":1377129600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"},{"start":{"date-parts":[[2013,8,22]],"date-time":"2013-08-22T00:00:00Z","timestamp":1377129600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/srep02469","type":"journal-article","created":{"date-parts":[[2013,8,22]],"date-time":"2013-08-22T09:08:16Z","timestamp":1377162496000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":95,"title":["The anti-malarial chloroquine overcomes Primary resistance and restores sensitivity to Trastuzumab in HER2-positive breast cancer"],"prefix":"10.1038","volume":"3","author":[{"given":"S\u00edlvia","family":"Cuf\u00ed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro","family":"Vazquez-Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Oliveras-Ferraros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruna","family":"Corominas-Faja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabet","family":"Cuy\u00e0s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugeni","family":"L\u00f3pez-Bonet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bego\u00f1a","family":"Martin-Castillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Joven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier A.","family":"Menendez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,8,22]]},"reference":[{"key":"BFsrep02469_CR1","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1038\/448645a","volume":"448","author":"CR Chong","year":"2007","unstructured":"Chong, C. R. & Sullivan, D. J. Jr. New uses for old drugs. Nature 448, 645\u2013646 (2007).","journal-title":"Nature"},{"key":"BFsrep02469_CR2","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1038\/nrd1468","volume":"3","author":"TT Ashburn","year":"2004","unstructured":"Ashburn, T. T. & Thor, K. B. Drug repositioning: identifying and developing new uses for existing drugs. Nat Rev Drug Discov 3, 673\u2013683 (2004).","journal-title":"Nat Rev Drug Discov"},{"key":"BFsrep02469_CR3","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1038\/nrd1178","volume":"2","author":"JM Reichert","year":"2003","unstructured":"Reichert, J. M. Trends in development and approval times for new therapeutics in the United States. Nat Rev Drug Discov 2, 695\u2013702 (2003).","journal-title":"Nat Rev Drug Discov"},{"key":"BFsrep02469_CR4","doi-asserted-by":"publisher","first-page":"5274","DOI":"10.1002\/anie.200200569","volume":"42","author":"J Wiesner","year":"2003","unstructured":"Wiesner, J., Ortmann, R., Jomaa, H. & Schlitzer, M. New antimalarial drugs. Angew Chem Int Ed Engl 42, 5274\u20135293 (2003).","journal-title":"Angew Chem Int Ed Engl"},{"key":"BFsrep02469_CR5","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1080\/00034983.1997.11813196","volume":"91","author":"AM Breckenridge","year":"1997","unstructured":"Breckenridge, A. M. & Winstanley, P. A. Clinical pharmacology and malaria. Ann Trop Med Parasitol 91, 727\u2013733 (1997).","journal-title":"Ann Trop Med Parasitol"},{"key":"BFsrep02469_CR6","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.ejphar.2009.06.063","volume":"625","author":"VR Solomon","year":"2009","unstructured":"Solomon, V. R. & Lee, H. Chloroquine and its analogs: a new promise of an old drug for effective and safe cancer therapies. Eur J Pharmacol 625, 220\u2013233 (2009).","journal-title":"Eur J Pharmacol"},{"key":"BFsrep02469_CR7","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1146\/annurev-genet-102808-114910","volume":"43","author":"C He","year":"2009","unstructured":"He, C. & Klionsky, D. J. Regulation mechanisms and signaling pathways of autophagy. Annu Rev Genet 43, 67\u201393 (2009).","journal-title":"Annu Rev Genet"},{"key":"BFsrep02469_CR8","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1126\/science.290.5497.1717","volume":"290","author":"DJ Klionsky","year":"2000","unstructured":"Klionsky, D. J. & Emr, S. D. Autophagy as a regulated pathway of cellular degradation. Science 290, 1717\u20131721 (2000).","journal-title":"Science"},{"key":"BFsrep02469_CR9","doi-asserted-by":"publisher","first-page":"2201","DOI":"10.1089\/ars.2010.3482","volume":"14","author":"I Tanida","year":"2011","unstructured":"Tanida, I. Autophagosome formation and molecular mechanism of autophagy. Antioxid Redox Signal 14, 2201\u20132214 (2011).","journal-title":"Antioxid Redox Signal"},{"key":"BFsrep02469_CR10","doi-asserted-by":"publisher","first-page":"73","DOI":"10.3858\/emm.2012.44.2.029","volume":"44","author":"JO Pyo","year":"2012","unstructured":"Pyo, J. O., Nah, J. & Jung, Y. K. Molecules and their functions in autophagy. Exp Mol Med 44, 73\u201380 (2012).","journal-title":"Exp Mol Med"},{"key":"BFsrep02469_CR11","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1158\/1535-7163.MCT-11-0047","volume":"10","author":"ZJ Yang","year":"2011","unstructured":"Yang, Z. J., Chee, C. E., Huang, S. & Sinicrope, F. A. The role of autophagy in cancer: therapeutic implications. Mol Cancer Ther 10, 1533\u20131541 (2011).","journal-title":"Mol Cancer Ther"},{"key":"BFsrep02469_CR12","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1016\/j.bcp.2011.05.023","volume":"82","author":"V Giansanti","year":"2011","unstructured":"Giansanti, V. et al. Killing of tumor cells: a drama in two acts. Biochem Pharmacol 82, 1304\u20131310 (2011).","journal-title":"Biochem Pharmacol"},{"key":"BFsrep02469_CR13","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1038\/nrclinonc.2011.71","volume":"8","author":"F Janku","year":"2011","unstructured":"Janku, F., McConkey, D. J., Hong, D. S. & Kurzrock, R. Autophagy as a target for anticancer therapy. Nat Rev Clin Oncol 8, 528\u2013539 (2011).","journal-title":"Nat Rev Clin Oncol"},{"key":"BFsrep02469_CR14","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1158\/1078-0432.CCR-10-2634","volume":"17","author":"RK Amaravadi","year":"2011","unstructured":"Amaravadi, R. K. et al. Principles and current strategies for targeting autophagy for cancer treatment. Clin Cancer Res 17, 654\u2013666 (2011).","journal-title":"Clin Cancer Res"},{"key":"BFsrep02469_CR15","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.18632\/oncotarget.384","volume":"2","author":"JD Mancias","year":"2011","unstructured":"Mancias, J. D. & Kimmelman, A. C. Targeting autophagy addiction in cancer. Oncotarget 2, 1302\u20131306 (2011).","journal-title":"Oncotarget"},{"key":"BFsrep02469_CR16","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1128\/MCB.25.3.1025-1040.2005","volume":"25","author":"P Boya","year":"2005","unstructured":"Boya, P. et al. Inhibition of macroautophagy triggers apoptosis. Mol Cell Biol 25, 1025\u20131040 (2005).","journal-title":"Mol Cell Biol"},{"key":"BFsrep02469_CR17","doi-asserted-by":"publisher","first-page":"7888","DOI":"10.1016\/j.bmc.2008.07.076","volume":"16","author":"C Hu","year":"2008","unstructured":"Hu, C., Solomon, V. R., Ulibarri, G. & Lee, H. The efficacy and selectivity of tumor cell killing by Akt inhibitors are substantially increased by chloroquine. Bioorg Med Chem 16, 7888\u20137893 (2008).","journal-title":"Bioorg Med Chem"},{"key":"BFsrep02469_CR18","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/j.biopha.2010.06.004","volume":"64","author":"PD Jiang","year":"2010","unstructured":"Jiang, P. D. et al. Antitumor and antimetastatic activities of chloroquine diphosphate in a murine model of breast cancer. Biomed Pharmacother 64, 609\u2013614 (2010).","journal-title":"Biomed Pharmacother"},{"key":"BFsrep02469_CR19","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1083\/jcb.200801099","volume":"183","author":"M Degtyarev","year":"2008","unstructured":"Degtyarev, M. et al. Akt inhibition promotes autophagy and sensitizes PTEN-null tumors to lysosomotropic agents. J Cell Biol 183, 101\u2013116 (2008).","journal-title":"J Cell Biol"},{"key":"BFsrep02469_CR20","doi-asserted-by":"publisher","first-page":"ra81","DOI":"10.1126\/scisignal.2001017","volume":"3","author":"QW Fan","year":"2010","unstructured":"Fan, Q. W. et al. Akt and autophagy cooperate to promote survival of drug-resistant glioma. Sci Signal 3, ra81 (2010).","journal-title":"Sci Signal"},{"key":"BFsrep02469_CR21","doi-asserted-by":"publisher","first-page":"200","DOI":"10.4161\/auto.8.2.18554","volume":"8","author":"P Maycotte","year":"2012","unstructured":"Maycotte, P. et al. Chloroquine sensitizes breast cancer cells to chemotherapy independent of autophagy. Autophagy 8, 200\u2013212 (2012).","journal-title":"Autophagy"},{"key":"BFsrep02469_CR22","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.4161\/auto.20828","volume":"8","author":"SM Gorski","year":"2012","unstructured":"Gorski, S. M., Ries, J. & Lum, J. J. Targeting autophagy: The Achilles' heel of cancer. Autophagy 8, 1279\u20131280 (2012).","journal-title":"Autophagy"},{"key":"BFsrep02469_CR23","doi-asserted-by":"publisher","first-page":"8253","DOI":"10.1073\/pnas.1118193109","volume":"109","author":"Q McAfee","year":"2012","unstructured":"McAfee, Q. et al. Autophagy inhibitor Lys05 has single-agent antitumor activity and reproduces the phenotype of a genetic autophagy deficiency. Proc Natl Acad Sci U S A 109, 8253\u20138258 (2012).","journal-title":"Proc Natl Acad Sci U S A"},{"key":"BFsrep02469_CR24","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.4161\/auto.20958","volume":"8","author":"RK Amaravadi","year":"2012","unstructured":"Amaravadi, R. K. & Winkler, J. D. Lys05: A new lysosomal autophagy inhibitor. Autophagy 8, 1383\u20131384 (2012).","journal-title":"Autophagy"},{"key":"BFsrep02469_CR25","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.cell.2011.08.037","volume":"147","author":"J Liu","year":"2011","unstructured":"Liu, J. et al. Beclin1 controls the levels of p53 by regulating the deubiquitination activity of USP10 and USP13. Cell 147, 223\u2013234 (2011).","journal-title":"Cell"},{"key":"BFsrep02469_CR26","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1158\/1535-7163.1585.3.12","volume":"3","author":"M Tanner","year":"2004","unstructured":"Tanner, M. et al. Characterization of a novel cell line established from a patient with Herceptin-resistant breast cancer. Mol Cancer Ther 3, 1585\u20131592 (2004).","journal-title":"Mol Cancer Ther"},{"key":"BFsrep02469_CR27","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1158\/0008-5472.473.65.2","volume":"65","author":"P Nagy","year":"2005","unstructured":"Nagy, P. et al. Decreased accessibility and lack of activation of ErbB2 in JIMT-1, a herceptin-resistant, MUC4-expressing breast cancer cell line. Cancer Res 65, 473\u2013482 (2005).","journal-title":"Cancer Res"},{"key":"BFsrep02469_CR28","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.canlet.2010.02.002","volume":"294","author":"K K\u00f6ninki","year":"2010","unstructured":"K\u00f6ninki, K. et al. Multiple molecular mechanisms underlying trastuzumab and lapatinib resistance in JIMT-1 breast cancer cells. Cancer Lett 294, 211\u2013219 (2010).","journal-title":"Cancer Lett"},{"key":"BFsrep02469_CR29","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1007\/s10549-010-0924-x","volume":"126","author":"A Vazquez-Martin","year":"2011","unstructured":"Vazquez-Martin, A., Oliveras-Ferraros, C., Del Barco, S., Martin-Castillo, B. & Menendez, J. A. The anti-diabetic drug metformin suppresses self-renewal and proliferation of trastuzumab-resistant tumor-initiating breast cancer stem cells. Breast Cancer Res Treat 126, 355\u2013364 (2011).","journal-title":"Breast Cancer Res Treat"},{"key":"BFsrep02469_CR30","doi-asserted-by":"publisher","first-page":"6921","DOI":"10.1158\/1078-0432.CCR-09-1599","volume":"15","author":"V Damiano","year":"2009","unstructured":"Damiano, V. et al. A novel toll-like receptor 9 agonist cooperates with trastuzumab in trastuzumab-resistant breast tumors through multiple mechanisms of action. Clin Cancer Res 15, 6921\u20136930 (2009).","journal-title":"Clin Cancer Res"},{"key":"BFsrep02469_CR31","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.bbrc.2010.05.041","volume":"397","author":"C Oliveras-Ferraros","year":"2010","unstructured":"Oliveras-Ferraros, C. et al. Dynamic emergence of the mesenchymal CD44(pos)CD24(neg\/low) phenotype in HER2-gene amplified breast cancer cells with de novo resistance to trastuzumab (Herceptin). Biochem Biophys Res Commun 397, 27\u201333 (2010).","journal-title":"Biochem Biophys Res Commun"},{"key":"BFsrep02469_CR32","first-page":"669","volume":"37","author":"C Oliveras-Ferraros","year":"2010","unstructured":"Oliveras-Ferraros, C. et al. Pathway-focused proteomic signatures in HER2-overexpressing breast cancer with a basal-like phenotype: new insights into de novo resistance to trastuzumab (Herceptin). Int J Oncol 37, 669\u2013678 (2010).","journal-title":"Int J Oncol"},{"key":"BFsrep02469_CR33","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s10549-010-1281-5","volume":"130","author":"G Valabrega","year":"2011","unstructured":"Valabrega, G. et al. HER2-positive breast cancer cells resistant to trastuzumab and lapatinib lose reliance upon HER2 and are sensitive to the multitargeted kinase inhibitor sorafenib. Breast Cancer Res Treat 130, 29\u201340 (2011).","journal-title":"Breast Cancer Res Treat"},{"key":"BFsrep02469_CR34","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/j.bbrc.2011.03.039","volume":"407","author":"C Oliveras-Ferraros","year":"2011","unstructured":"Oliveras-Ferraros, C. et al. Inhibitor of Apoptosis (IAP) survivin is indispensable for survival of HER2 gene-amplified breast cancer cells with primary resistance to HER1\/2-targeted therapies. Biochem Biophys Res Commun 407, 412\u2013419 (2011).","journal-title":"Biochem Biophys Res Commun"},{"key":"BFsrep02469_CR35","doi-asserted-by":"publisher","first-page":"395","DOI":"10.18632\/oncotarget.488","volume":"3","author":"S Cufi","year":"2012","unstructured":"Cufi, S. et al. Metformin-induced preferential killing of breast cancer initiating CD44+CD24-\/low cells is sufficient to overcome primary resistance to trastuzumab in HER2+ human breast cancer xenografts. Oncotarget 3, 395\u2013398 (2012).","journal-title":"Oncotarget"},{"key":"BFsrep02469_CR36","doi-asserted-by":"publisher","first-page":"4020","DOI":"10.4161\/cc.22225","volume":"11","author":"C Oliveras-Ferraros","year":"2012","unstructured":"Oliveras-Ferraros, C. et al. Epithelial-to-mesenchymal transition (EMT) confers primary resistance to trastuzumab (Herceptin). Cell Cycle 11, 4020\u20134032 (2012).","journal-title":"Cell Cycle"},{"key":"BFsrep02469_CR37","doi-asserted-by":"publisher","first-page":"2065","DOI":"10.1158\/1535-7163.MCT-06-0766","volume":"6","author":"M Barok","year":"2007","unstructured":"Barok, M. et al. Trastuzumab causes antibody-dependent cellular cytotoxicity-mediated growth inhibition of submacroscopic JIMT-1 breast cancer xenografts despite intrinsic drug resistance. Mol Cancer Ther 6, 2065\u20132072 (2007).","journal-title":"Mol Cancer Ther"},{"key":"BFsrep02469_CR38","doi-asserted-by":"publisher","first-page":"e13859","DOI":"10.1371\/journal.pone.0013859","volume":"5","author":"L Ahtiainen","year":"2010","unstructured":"Ahtiainen, L. et al. Defects in innate immunity render breast cancer initiating cells permissive to oncolytic adenovirus. PLoS One 5, e13859 (2010).","journal-title":"PLoS One"},{"key":"BFsrep02469_CR39","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1038\/nrd2272","volume":"6","author":"DC Rubinsztein","year":"2007","unstructured":"Rubinsztein, D. C., Gestwicki, J. E., Murphy, L. O. & Klionsky, D. J. Potential therapeutic applications of autophagy. Nat Rev Drug Discov 6, 304\u2013312 (2007).","journal-title":"Nat Rev Drug Discov"},{"key":"BFsrep02469_CR40","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.cell.2010.01.028","volume":"140","author":"N Mizushima","year":"2010","unstructured":"Mizushima, N., Yoshimori, T. & Levine, B. Methods in mammalian autophagy Research. Cell 140, 313\u2013326 (2010).","journal-title":"Cell"},{"key":"BFsrep02469_CR41","doi-asserted-by":"publisher","first-page":"445","DOI":"10.4161\/auto.19496","volume":"8","author":"DJ Klionsky","year":"2012","unstructured":"Klionsky, D. J. et al. Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy 8, 445\u2013544 (2012).","journal-title":"Autophagy"},{"key":"BFsrep02469_CR42","doi-asserted-by":"publisher","first-page":"5641","DOI":"10.1074\/jbc.M609532200","volume":"282","author":"S Sarkar","year":"2007","unstructured":"Sarkar, S., Davies, J. E., Huang, Z., Tunnacliffe, A. & Rubinsztein, D. C. Trehalose, a novel mTOR-independent autophagy enhancer, accelerates the clearance of mutant huntingtin and alpha-synuclein. J Biol Chem 282, 5641\u20135652 (2007).","journal-title":"J Biol Chem"},{"key":"BFsrep02469_CR43","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.18632\/oncotarget.742","volume":"3","author":"S Cuf\u00ed","year":"2012","unstructured":"Cuf\u00ed, S. et al. Autophagy-related gene 12 (ATG12) is a novel determinant of primary resistance to HER2-targeted therapies: Utility of transcriptome analysis of the autophagy interactome to guide breast cancer treatment. Oncotarget 3, 1600\u20131614 (2012).","journal-title":"Oncotarget"},{"key":"BFsrep02469_CR44","doi-asserted-by":"publisher","first-page":"e6251","DOI":"10.1371\/journal.pone.0006251","volume":"4","author":"A Vazquez-Martin","year":"2009","unstructured":"Vazquez-Martin, A., Oliveras-Ferraros, C. & Menendez, J. A. Autophagy facilitates the development of breast cancer resistance to the anti-HER2 monoclonal antibody trastuzumab. PLoS One 4, e6251 (2009).","journal-title":"PLoS One"},{"key":"BFsrep02469_CR45","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1083\/jcb.200507002","volume":"171","author":"G Bj\u00f8rk\u00f8y","year":"2005","unstructured":"Bj\u00f8rk\u00f8y, G. et al. p62\/SQSTM1 forms protein aggregates degraded by autophagy and has a protective effect on huntingtin-induced cell death. J Cell Biol 171, 603\u2013614 (2005).","journal-title":"J Cell Biol"},{"key":"BFsrep02469_CR46","doi-asserted-by":"publisher","first-page":"138","DOI":"10.4161\/auto.2.2.2405","volume":"2","author":"G Bj\u00f8rk\u00f8y","year":"2006","unstructured":"Bj\u00f8rk\u00f8y, G., Lamark, T. & Johansen, T. p62\/SQSTM1: a missing link between protein aggregates and the autophagy machinery. Autophagy 2, 138\u2013139 (2006).","journal-title":"Autophagy"},{"key":"BFsrep02469_CR47","doi-asserted-by":"publisher","first-page":"24131","DOI":"10.1074\/jbc.M702824200","volume":"282","author":"S Pankiv","year":"2007","unstructured":"Pankiv, S. et al. p62\/SQSTM1 binds directly to Atg8\/LC3 to facilitate degradation of ubiquitinated protein aggregates by autophagy. J Biol Chem 282, 24131\u201324145 (2007).","journal-title":"J Biol Chem"},{"key":"BFsrep02469_CR48","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.4161\/auto.6826","volume":"4","author":"Y Ichimura","year":"2008","unstructured":"Ichimura, Y., Kominami, E., Tanaka, K. & Komatsu, M. Selective turnover of p62\/A170\/SQSTM1 by autophagy. Autophagy 4, 1063\u20131066 (2008).","journal-title":"Autophagy"},{"key":"BFsrep02469_CR49","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.4161\/auto.6823","volume":"4","author":"E Shvets","year":"2008","unstructured":"Shvets, E. & Elazar, Z. Autophagy-independent incorporation of GFP-LC3 into protein aggregates is dependent on its interaction with p62\/SQSTM1. Autophagy 4, 1054\u20131056 (2008).","journal-title":"Autophagy"},{"key":"BFsrep02469_CR50","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1038\/sj.cdd.4401765","volume":"12","author":"T Yorimitsu","year":"2005","unstructured":"Yorimitsu, T. & Klionsky, D. J. Autophagy: molecular machinery for self-eating. Cell Death Differ 12, 1542\u20131552 (2005).","journal-title":"Cell Death Differ"},{"key":"BFsrep02469_CR51","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1038\/ncb1007-1102","volume":"9","author":"Z Xie","year":"2007","unstructured":"Xie, Z. & Klionsky, D. J. Autophagosome formation: core machinery and adaptations. Nat Cell Biol 9, 1102\u20131109 (2007).","journal-title":"Nat Cell Biol"},{"key":"BFsrep02469_CR52","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1038\/embor.2008.163","volume":"9","author":"J Geng","year":"2008","unstructured":"Geng, J. & Klionsky, D. J. The Atg8 and Atg12 ubiquitin-like conjugation systems in macroautophagy. 'Protein modifications: beyond the usual suspects' review series. EMBO Rep 9, 859\u2013864 (2008).","journal-title":"EMBO Rep"},{"key":"BFsrep02469_CR53","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1146\/annurev-cellbio-092910-154005","volume":"27","author":"N Mizushima","year":"2011","unstructured":"Mizushima, N., Yoshimori, T. & Ohsumi, Y. The role of Atg proteins in autophagosome formation. Annu Rev Cell Dev Biol 27, 107\u2013132 (2011).","journal-title":"Annu Rev Cell Dev Biol"},{"key":"BFsrep02469_CR54","doi-asserted-by":"publisher","first-page":"3871","DOI":"10.4161\/cc.10.22.17976","volume":"10","author":"S Cuf\u00ed","year":"2011","unstructured":"Cuf\u00ed, S., Vazquez-Martin, A., Oliveras-Ferraros, C., Martin-Castillo, B., Vellon, L. & Menendez, J. A. Autophagy positively regulates the CD44(+) CD24(-\/low) breast cancer stem-like phenotype. Cell Cycle 10, 3871\u20133885 (2011).","journal-title":"Cell Cycle"},{"key":"BFsrep02469_CR55","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1083\/jcb.200801099","volume":"183","author":"M Degtyarev","year":"2008","unstructured":"Degtyarev, M. et al. Akt inhibition promotes autophagy and sensitizes PTEN-null tumors to lysosomotropic agents. J Cell Biol 183, 101\u2013116 (2008).","journal-title":"J Cell Biol"},{"key":"BFsrep02469_CR56","doi-asserted-by":"publisher","first-page":"ra81","DOI":"10.1126\/scisignal.2001017","volume":"3","author":"QW Fan","year":"2010","unstructured":"Fan, Q. W. et al. Akt and autophagy cooperate to promote survival of drug-resistant glioma. Sci Signal 3, ra81 (2010).","journal-title":"Sci Signal"},{"key":"BFsrep02469_CR57","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan, D. & Weinberg, R. A. Hallmarks of cancer: the next generation. Cell 144, 646\u2013674 (2011).","journal-title":"Cell"},{"key":"BFsrep02469_CR58","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.ccr.2012.02.014","volume":"21","author":"PS Ward","year":"2012","unstructured":"Ward, P. S. & Thompson, C. B. Metabolic reprogramming: a cancer hallmark even warburg did not anticipate. Cancer Cell 21, 297\u2013308 (2012).","journal-title":"Cancer Cell"},{"key":"BFsrep02469_CR59","doi-asserted-by":"publisher","first-page":"e9715","DOI":"10.1371\/journal.pone.0009715","volume":"5","author":"Y Cheng","year":"2010","unstructured":"Cheng, Y., Li, H., Ren, X., Niu, T., Hait, W. N. & Yang, J. Cytoprotective effect of the elongation factor-2 kinase-mediated autophagy in breast cancer cells subjected to growth factor inhibition. PLoS One 5, e9715 (2010).","journal-title":"PLoS One"},{"key":"BFsrep02469_CR60","doi-asserted-by":"publisher","first-page":"e29014","DOI":"10.1371\/journal.pone.0029014","volume":"6","author":"HL Huang","year":"2011","unstructured":"Huang, H. L. et al. Lapatinib induces autophagy, apoptosis and megakaryocytic differentiation in chronic myelogenous leukemia K562 cells. PLoS One 6, e29014 (2011).","journal-title":"PLoS One"},{"key":"BFsrep02469_CR61","doi-asserted-by":"publisher","first-page":"e18691","DOI":"10.1371\/journal.pone.0018691","volume":"6","author":"W Han","year":"2011","unstructured":"Han, W. et al. EGFR tyrosine kinase inhibitors activate autophagy as a cytoprotective response in human lung cancer cells. PLoS One 6, e18691 (2011).","journal-title":"PLoS One"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep02469","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep02469.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep02469.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,6]],"date-time":"2023-01-06T05:04:20Z","timestamp":1672981460000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep02469"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8,22]]},"references-count":61,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2013,12,20]]}},"alternative-id":["BFsrep02469"],"URL":"https:\/\/doi.org\/10.1038\/srep02469","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,8,22]]},"assertion":[{"value":"12 March 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2013","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2013","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2469"}}